Oxaliplatin-Induced Lung Injury with Allergic Reaction

A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen.On the 12th cycle,we observed erythema and dyspnea.Radiographs showed ground grass opacities.Blood tests showed elevated levels of eosinophils and immunoglobulin E.We diagnosed this findin...

Full description

Saved in:
Bibliographic Details
Published in:Chinese journal of cancer research Vol. 23; no. 3; pp. 232 - 235
Main Authors: Homma, Tetsuya, Kurokawa, Masatsugu, Yamamoto, Yoshitaka, Matsukura, Satoshi, Ieki, Koushi, Suzuki, Shintaro, Odaka, Miho, Watanabe, Shin, Yamaguchi, Munehiro, Adachi, Mitsuru
Format: Journal Article
Language:English
Published: Heidelberg Chinese Anti-Cancer Association 01-09-2011
Springer-Verlag Berlin Heidelberg
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen.On the 12th cycle,we observed erythema and dyspnea.Radiographs showed ground grass opacities.Blood tests showed elevated levels of eosinophils and immunoglobulin E.We diagnosed this finding as response to drug allergy and administered high-dose methylprednisolone.The treatment was successful and he was discharged.The drug lymphocyte stimulating test against oxaliplatin was positive,indicating a type I and IV allergic reaction due to oxaliplatin.Regimens including oxaliplatin must be carefully monitored and frequent blood tests and chest radiographs are needed.
AbstractList A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen. On the 12th cycle, we observed erythema and dyspnea. Radiographs showed ground grass opacities. Blood tests showed elevated levels of eosinophils and immunoglobulin E. We diagnosed this finding as response to drug allergy and administered high-dose methylprednisolone. The treatment was successful and he was discharged. The drug lymphocyte stimulating test against oxaliplatin was positive, indicating a type I and IV allergic reaction due to oxaliplatin. Regimens including oxaliplatin must be carefully monitored and frequent blood tests and chest radiographs are needed.
A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen.On the 12th cycle,we observed erythema and dyspnea.Radiographs showed ground grass opacities.Blood tests showed elevated levels of eosinophils and immunoglobulin E.We diagnosed this finding as response to drug allergy and administered high-dose methylprednisolone.The treatment was successful and he was discharged.The drug lymphocyte stimulating test against oxaliplatin was positive,indicating a type I and IV allergic reaction due to oxaliplatin.Regimens including oxaliplatin must be carefully monitored and frequent blood tests and chest radiographs are needed.
Author Tetsuya Homma Masatsugu Kuro.kawa Yoshitaka Yamamoto Satoshi Matsukura Koushi leki Shintaro Suzuki Miho Oclaka Shin Watanabe Munehiro Yamaguchi Mitsuru Adachi
AuthorAffiliation Division of AIlergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University,1-5-8 Hatanodai, 5hinagawa-ku, Tokyo, Japan
Author_xml – sequence: 1
  givenname: Tetsuya
  surname: Homma
  fullname: Homma, Tetsuya
  email: oldham726@yahoo.co.jp
  organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University
– sequence: 2
  givenname: Masatsugu
  surname: Kurokawa
  fullname: Kurokawa, Masatsugu
  organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University
– sequence: 3
  givenname: Yoshitaka
  surname: Yamamoto
  fullname: Yamamoto, Yoshitaka
  organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University
– sequence: 4
  givenname: Satoshi
  surname: Matsukura
  fullname: Matsukura, Satoshi
  organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University
– sequence: 5
  givenname: Koushi
  surname: Ieki
  fullname: Ieki, Koushi
  organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University
– sequence: 6
  givenname: Shintaro
  surname: Suzuki
  fullname: Suzuki, Shintaro
  organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University
– sequence: 7
  givenname: Miho
  surname: Odaka
  fullname: Odaka, Miho
  organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University
– sequence: 8
  givenname: Shin
  surname: Watanabe
  fullname: Watanabe, Shin
  organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University
– sequence: 9
  givenname: Munehiro
  surname: Yamaguchi
  fullname: Yamaguchi, Munehiro
  organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University
– sequence: 10
  givenname: Mitsuru
  surname: Adachi
  fullname: Adachi, Mitsuru
  organization: Division of Allergology and Respiratory Medicine, Division of Internal Medicine, School of Medicine, Showa University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23467619$$D View this record in MEDLINE/PubMed
BookMark eNp9kdtKAzEQhoMo1tMDeCPrA0Rnkk3S3AgiHgoFQfQ6pNnsdss2W7O7at_eSLXojVczMPN_E74ckt3QBk_IKcIFAqjLDlEqoIBIgXFG1zvkALXmFCTH3dQDANUS8hE57LoFgFACcJ-MGM-lkqgPiHz8sE29amxfBzoJxeB8kU2HUGWTsBjiOnuv-3l23TQ-VrXLnrx1fd2GY7JX2qbzJ9_1iLzc3T7fPNDp4_3k5npKXc5FT7XVTnEmnSshx5nmUs_GJQcNKJhAXsxwXCip8pxZhcqWOi-1YqlyzoQU_IhcbbirYbb0hfOhj7Yxq1gvbVyb1tbm7yTUc1O1b4aLsRISEwA3ABfbrou-3GYRzJdEs5FokkTzJdGsU-bs99Ft4sdaWmCbhS6NQuWjWbRDDEnEv9Tz75fM21C9ptwWnKefASYY_wTuZ4nD
CitedBy_id crossref_primary_10_1186_s12885_017_3576_y
crossref_primary_10_1159_000368185
Cites_doi 10.1200/JCO.2006.09.6305
10.1056/NEJMoa032709
10.1007/BF02717006
10.1016/j.rmed.2007.09.001
10.1378/chest.07-0536
10.3816/CCC.2010.n.024
10.2174/092986707779313345
10.1007/s12094-009-0364-4
10.1007/s10147-008-0863-2
10.1007/s12094-006-0072-2
10.1093/annonc/mdh095
10.1097/00000421-200208000-00014
10.1159/000127425
10.1093/annonc/mdq061
10.1159/000107467
10.1056/NEJMoa071834
10.1007/s12094-008-0285-7
10.1038/clpt.1981.154
10.1038/sj.bjc.6602064
10.1111/j.1743-7563.2008.00187.x
10.1200/JCO.2002.20.4.1146
10.3748/wjg.v12.i36.5907
10.1155/2010/207084
10.1183/09031936.93.05070791
10.1183/09031936.01.18010243
ContentType Journal Article
Copyright Chinese Anti-Cancer Association and Springer-Verlag Berlin Heidelberg 2011
2011 Chinese Anti-Cancer Association and Springer-Verlag Berlin Heidelberg 2011 2011 Chinese Anti-Cancer Association and Springer-Verlag Berlin Heidelberg
Copyright_xml – notice: Chinese Anti-Cancer Association and Springer-Verlag Berlin Heidelberg 2011
– notice: 2011 Chinese Anti-Cancer Association and Springer-Verlag Berlin Heidelberg 2011 2011 Chinese Anti-Cancer Association and Springer-Verlag Berlin Heidelberg
DBID 2RA
92L
CQIGP
W91
~WA
NPM
AAYXX
CITATION
5PM
DOI 10.1007/s11670-011-0232-y
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
PubMed
CrossRef
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
DatabaseTitleList

PubMed

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Oxaliplatin-Induced Lung Injury with Allergic Reaction
EISSN 1993-0631
EndPage 235
ExternalDocumentID 10_1007_s11670_011_0232_y
23467619
40050252
Genre Case Reports
GroupedDBID ---
-05
-0E
-5E
-5G
-BR
-SE
-S~
-Y2
.86
0R~
0VY
1N0
2.D
29B
2B.
2C~
2JY
2RA
2VQ
2~H
30V
4.4
408
40D
5GY
5VR
5VS
5XA
5XF
5XL
6NX
8TC
8UJ
92F
92I
92L
92M
93N
93R
95.
95~
9D9
9DE
AAIAL
AANXM
AARHV
ABJNI
ABKZE
ABTEG
ACGFS
ACOMO
ADINQ
ADKPE
ADQRH
ADRFC
AENEX
AFLOW
AFNRJ
AFUIB
AFWTZ
AGGDS
AGJBK
AHBYD
AHKAY
AHSBF
ALMA_UNASSIGNED_HOLDINGS
AMKLP
ASPBG
AVWKF
AZFZN
BA0
BBWZM
BGNMA
CAG
CAJEE
CAJUS
CCEZO
CHBEP
CIEJG
COF
CQIGP
CS3
CSCUP
CW9
DIK
DU5
EBS
EJD
FA0
FEDTE
GQ6
GX1
HF~
HG6
HMJXF
HVGLF
HYE
HZ~
I~X
M4Y
MA-
N2Q
NDZJH
NF0
NU0
O9-
O93
O9G
O9I
OK1
OVD
P19
P9S
PT5
Q--
Q-4
QOK
QOS
R-E
R89
R9I
RNI
ROL
RPM
RPX
RSV
RT5
RZK
S1Z
S26
S27
S28
S37
S3B
SCL
SDE
SDH
SMD
SOJ
SZN
T13
T16
T8U
TCJ
TEORI
TGQ
TT1
TUC
U1F
U1G
U2A
U5E
U5O
VC2
W91
WFFXF
WK8
~A9
~N8
~WA
AAPBV
AAXDM
AAYZH
AFBBN
NPM
AAYXX
CITATION
5PM
ID FETCH-LOGICAL-c435t-9a9c7326ccf041b9369b8f3090152513db18d767442a717af94f972af93325653
IEDL.DBID RPM
ISSN 1000-9604
IngestDate Tue Sep 17 21:02:26 EDT 2024
Thu Nov 21 21:11:22 EST 2024
Wed Oct 16 00:50:16 EDT 2024
Sat Dec 16 12:02:50 EST 2023
Wed Feb 14 10:48:17 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Immunoglobulin E
Oxaliplatin
Drug-induced pneumonia
mFOLFOX6
Drug lymphocyte stimulating test
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c435t-9a9c7326ccf041b9369b8f3090152513db18d767442a717af94f972af93325653
Notes A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen.On the 12th cycle,we observed erythema and dyspnea.Radiographs showed ground grass opacities.Blood tests showed elevated levels of eosinophils and immunoglobulin E.We diagnosed this finding as response to drug allergy and administered high-dose methylprednisolone.The treatment was successful and he was discharged.The drug lymphocyte stimulating test against oxaliplatin was positive,indicating a type I and IV allergic reaction due to oxaliplatin.Regimens including oxaliplatin must be carefully monitored and frequent blood tests and chest radiographs are needed.
11-2591/R
Oxaliplatin; mFOLFOX6; Drug-induced pneumonia; Drug lymphocyte stimulating test; Immunoglobulin E
Tetsuya Homma,Masatsugu Kurokawa,Yoshitaka Yamamoto,Satoshi Matsukura,Koushi Ieki,Shintaro Suzuki,Miho Odaka,Shin Watanabe,Munehiro Yamaguchi,Mitsuru Adachi (Division of Allergology and Respiratory Medicine,Division of Internal Medicine,School of Medicine,Showa University,1-5-8 Hatanodai,Shinagawa-ku,Tokyo,Japan)
E-mail: oldham726@yahoo.co.jp
Corresponding author.
OpenAccessLink https://europepmc.org/articles/pmc3587561?pdf=render
PMID 23467619
PageCount 4
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3587561
crossref_primary_10_1007_s11670_011_0232_y
pubmed_primary_23467619
springer_journals_10_1007_s11670_011_0232_y
chongqing_primary_40050252
PublicationCentury 2000
PublicationDate 2011-09-01
PublicationDateYYYYMMDD 2011-09-01
PublicationDate_xml – month: 09
  year: 2011
  text: 2011-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Heidelberg
PublicationPlace_xml – name: Heidelberg
– name: China
PublicationTitle Chinese journal of cancer research
PublicationTitleAbbrev Chin. J. Cancer Res
PublicationTitleAlternate Chinese Journal of Cancer Research
PublicationYear 2011
Publisher Chinese Anti-Cancer Association
Springer-Verlag Berlin Heidelberg
Publisher_xml – name: Chinese Anti-Cancer Association
– name: Springer-Verlag Berlin Heidelberg
References Costabel, Teschler, Guzman (CR4) 1992; 5
Pena Alvarez, Suh Oh, Sáenz de Miera Rodríguez (CR20) 2009; 11
Arévalo Lobera, Sagastibeltza Mariñelarena, Elejoste Echeberría (CR18) 2008; 10
Pagani, Bonadonna, Senna (CR25) 2008; 145
Trisolini, Lazzari Agli, Tassinari (CR9) 2001; 18
Piccolo, Feeney, Tribe (CR19) 2008; 4
Muneoka, Shirai, Sasaki (CR21) 2009; 14
Jung, Kil, Choi (CR13) 2006; 10
Ohori, Takahashi, Ogasawara (CR24) 2009; 36
Yagüe, Soy, Merino (CR11) 2005; 7
Garrido, O’Brien, González (CR16) 2007; 132
Rowinsky, Eisenhauer, Chaudhry (CR28) 1993; 20
Kinnula, Vuorinen, Ilumets (CR6) 2007; 14
CR3
Wilcox, Ryu, Kalra (CR17) 2008; 102
Fekrazad, Eberhardt, Jones (CR22) 2010; 9
Shimura, Fuse, Yoshino (CR23) 2010; 21
Mundt, Mochmann, Ebhardt (CR15) 2007; 73
Rubbia-Brandt, Audard, Sartoretti (CR5) 2004; 15
Naranjo, Busto, Sellers (CR8) 1981; 30
André, Boni, Mounedji-Boudiaf (CR1) 2004; 350
Giantonio, Catalano, Meropol (CR27) 2007; 25
Pasetto, Monfardini (CR14) 2006; 12
Jonker, O’Callaghan, Karapetis (CR26) 2007; 357
Müller, White, Jiang (CR7) 2004; 91
Gagnadoux, Roiron, Carrie (CR10) 2002; 25
Meyer, Zuberbier, Worm (CR2) 2002; 20
Ruiz-Casado, García, Racionero (CR12) 2006; 8
L.M. Pasetto (232_CR14) 2006; 12
D.J. Jonker (232_CR26) 2007; 357
A. Ruiz-Casado (232_CR12) 2006; 8
M. Garrido (232_CR16) 2007; 132
K. Muneoka (232_CR21) 2009; 14
U. Costabel (232_CR4) 1992; 5
V.L. Kinnula (232_CR6) 2007; 14
S. Arévalo Lobera (232_CR18) 2008; 10
T. Shimura (232_CR23) 2010; 21
R. Trisolini (232_CR9) 2001; 18
F. Gagnadoux (232_CR10) 2002; 25
M.H. Fekrazad (232_CR22) 2010; 9
K.H. Jung (232_CR13) 2006; 10
232_CR3
L. Rubbia-Brandt (232_CR5) 2004; 15
F. Piccolo (232_CR19) 2008; 4
C. Pena Alvarez (232_CR20) 2009; 11
C.A. Naranjo (232_CR8) 1981; 30
P. Mundt (232_CR15) 2007; 73
B.J. Giantonio (232_CR27) 2007; 25
E.K. Rowinsky (232_CR28) 1993; 20
T. André (232_CR1) 2004; 350
B.E. Wilcox (232_CR17) 2008; 102
L. Meyer (232_CR2) 2002; 20
N.L. Müller (232_CR7) 2004; 91
M. Pagani (232_CR25) 2008; 145
X.H. Yagüe (232_CR11) 2005; 7
H. Ohori (232_CR24) 2009; 36
References_xml – volume: 18
  start-page: 243
  year: 2001
  end-page: 245
  ident: CR9
  article-title: Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy
  publication-title: Eur Respir J
  contributor:
    fullname: Tassinari
– volume: 12
  start-page: 5907
  year: 2006
  end-page: 5908
  ident: CR14
  article-title: Is acute dyspnea related to oxaliplatin administration?
  publication-title: World J Gastroenterol
  contributor:
    fullname: Monfardini
– volume: 25
  start-page: 1539
  year: 2007
  end-page: 1544
  ident: CR27
  article-title: Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.09.6305
  contributor:
    fullname: Meropol
– volume: 350
  start-page: 2343
  year: 2004
  end-page: 2351
  ident: CR1
  article-title: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa032709
  contributor:
    fullname: Mounedji-Boudiaf
– volume: 20
  start-page: 1
  issue: 4Suppl3
  year: 1993
  end-page: 15
  ident: CR28
  article-title: Clinical toxicities encountered with paclitaxel (Taxol)
  publication-title: Semin Oncol
  contributor:
    fullname: Chaudhry
– volume: 7
  start-page: 515
  year: 2005
  end-page: 517
  ident: CR11
  article-title: Interstitial pneumonitis after oxaliplatin treatment in colorectal cancer
  publication-title: Clin Transl Oncol
  doi: 10.1007/BF02717006
  contributor:
    fullname: Merino
– volume: 102
  start-page: 273
  year: 2008
  end-page: 279
  ident: CR17
  article-title: Exacerbation of pre-existing interstitial lung disease after oxaliplatin therapy: a report of three cases
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2007.09.001
  contributor:
    fullname: Kalra
– volume: 10
  start-page: 1181
  year: 2006
  end-page: 1182
  ident: CR13
  article-title: Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)
  publication-title: Int J Tuberc Lung Dis
  contributor:
    fullname: Choi
– volume: 132
  start-page: 1997
  year: 2007
  end-page: 1999
  ident: CR16
  article-title: Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report
  publication-title: Chest
  doi: 10.1378/chest.07-0536
  contributor:
    fullname: González
– volume: 9
  start-page: 177
  year: 2010
  end-page: 178
  ident: CR22
  article-title: Development of bronchiolitis obliterans organizing pneumonia with platinum-based chemotherapy for metastatic rectal cancer
  publication-title: Clin Colorectal Cancer
  doi: 10.3816/CCC.2010.n.024
  contributor:
    fullname: Jones
– volume: 5
  start-page: 791
  year: 1992
  end-page: 797
  ident: CR4
  article-title: Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage
  publication-title: Eur Respir J
  contributor:
    fullname: Guzman
– volume: 14
  start-page: 213
  year: 2007
  end-page: 222
  ident: CR6
  article-title: Thiol proteins, redox modulation and parenchymal lung disease
  publication-title: Curr Med Chem
  doi: 10.2174/092986707779313345
  contributor:
    fullname: Ilumets
– volume: 36
  start-page: 295
  year: 2009
  end-page: 298
  ident: CR24
  article-title: Two cases of interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX)
  publication-title: Gan To Kagaku Ryoho
  contributor:
    fullname: Ogasawara
– volume: 11
  start-page: 332
  year: 2009
  end-page: 333
  ident: CR20
  article-title: Interstitial lung disease associated with oxaliplatin: description of two cases
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-009-0364-4
  contributor:
    fullname: Sáenz de Miera Rodríguez
– volume: 14
  start-page: 457
  year: 2009
  end-page: 459
  ident: CR21
  article-title: Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX)
  publication-title: Int J Clin Oncol
  doi: 10.1007/s10147-008-0863-2
  contributor:
    fullname: Sasaki
– volume: 8
  start-page: 624
  year: 2006
  ident: CR12
  article-title: Pulmonary toxicity of 5-fluoracil and oxaliplatin
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-006-0072-2
  contributor:
    fullname: Racionero
– volume: 15
  start-page: 460
  year: 2004
  end-page: 466
  ident: CR5
  article-title: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdh095
  contributor:
    fullname: Sartoretti
– volume: 25
  start-page: 388
  year: 2002
  end-page: 390
  ident: CR10
  article-title: Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer
  publication-title: Am J Clin Oncol
  doi: 10.1097/00000421-200208000-00014
  contributor:
    fullname: Carrie
– volume: 20
  start-page: 1146
  year: 2002
  end-page: 1147
  ident: CR2
  article-title: Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule
  publication-title: J Clin Oncol
  contributor:
    fullname: Worm
– volume: 73
  start-page: 270
  year: 2007
  end-page: 272
  ident: CR15
  article-title: Pulmonary fibrosis after chemotherapy with oxaliplatin and 5-fluorouracil for colorectal cancer
  publication-title: Oncology
  doi: 10.1159/000127425
  contributor:
    fullname: Ebhardt
– volume: 21
  start-page: 2005
  year: 2010
  end-page: 2010
  ident: CR23
  article-title: Clinical features of interstitial lung disease induced by standard chemotherapy (FOLFOX or FOLFIRI) for colorectal cancer
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdq061
  contributor:
    fullname: Yoshino
– volume: 145
  start-page: 54
  year: 2008
  end-page: 57
  ident: CR25
  article-title: Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin
  publication-title: Int Arch Allergy Immuno
  doi: 10.1159/000107467
  contributor:
    fullname: Senna
– ident: CR3
– volume: 357
  start-page: 2040
  year: 2007
  end-page: 2048
  ident: CR26
  article-title: Cetuximab for the treatment of colorectal cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa071834
  contributor:
    fullname: Karapetis
– volume: 10
  start-page: 764
  year: 2008
  end-page: 767
  ident: CR18
  article-title: Fatal pneumonitis induced by oxaliplatin
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-008-0285-7
  contributor:
    fullname: Elejoste Echeberría
– volume: 30
  start-page: 239
  year: 1981
  end-page: 245
  ident: CR8
  article-title: A method for estimating the probability of adverse drug reactions
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.1981.154
  contributor:
    fullname: Sellers
– volume: 91
  start-page: S24
  issue: 4Suppl3
  year: 2004
  end-page: S30
  ident: CR7
  article-title: Diagnosis and management of drug-associated interstitial lung disease
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6602064
  contributor:
    fullname: Jiang
– volume: 4
  start-page: 175
  year: 2008
  end-page: 180
  ident: CR19
  article-title: Oxaliplatin-induced interstitial lung disease
  publication-title: Asian Pacific J Clin Oncol
  doi: 10.1111/j.1743-7563.2008.00187.x
  contributor:
    fullname: Tribe
– volume: 21
  start-page: 2005
  year: 2010
  ident: 232_CR23
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdq061
  contributor:
    fullname: T. Shimura
– volume: 20
  start-page: 1146
  year: 2002
  ident: 232_CR2
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2002.20.4.1146
  contributor:
    fullname: L. Meyer
– volume: 8
  start-page: 624
  year: 2006
  ident: 232_CR12
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-006-0072-2
  contributor:
    fullname: A. Ruiz-Casado
– volume: 7
  start-page: 515
  year: 2005
  ident: 232_CR11
  publication-title: Clin Transl Oncol
  doi: 10.1007/BF02717006
  contributor:
    fullname: X.H. Yagüe
– volume: 30
  start-page: 239
  year: 1981
  ident: 232_CR8
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/clpt.1981.154
  contributor:
    fullname: C.A. Naranjo
– volume: 15
  start-page: 460
  year: 2004
  ident: 232_CR5
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdh095
  contributor:
    fullname: L. Rubbia-Brandt
– volume: 10
  start-page: 1181
  year: 2006
  ident: 232_CR13
  publication-title: Int J Tuberc Lung Dis
  contributor:
    fullname: K.H. Jung
– volume: 14
  start-page: 457
  year: 2009
  ident: 232_CR21
  publication-title: Int J Clin Oncol
  doi: 10.1007/s10147-008-0863-2
  contributor:
    fullname: K. Muneoka
– volume: 12
  start-page: 5907
  year: 2006
  ident: 232_CR14
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v12.i36.5907
  contributor:
    fullname: L.M. Pasetto
– volume: 10
  start-page: 764
  year: 2008
  ident: 232_CR18
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-008-0285-7
  contributor:
    fullname: S. Arévalo Lobera
– volume: 4
  start-page: 175
  year: 2008
  ident: 232_CR19
  publication-title: Asian Pacific J Clin Oncol
  doi: 10.1111/j.1743-7563.2008.00187.x
  contributor:
    fullname: F. Piccolo
– volume: 91
  start-page: S24
  issue: 4Suppl3
  year: 2004
  ident: 232_CR7
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6602064
  contributor:
    fullname: N.L. Müller
– volume: 36
  start-page: 295
  year: 2009
  ident: 232_CR24
  publication-title: Gan To Kagaku Ryoho
  contributor:
    fullname: H. Ohori
– volume: 73
  start-page: 270
  year: 2007
  ident: 232_CR15
  publication-title: Oncology
  doi: 10.1159/000127425
  contributor:
    fullname: P. Mundt
– ident: 232_CR3
  doi: 10.1155/2010/207084
– volume: 5
  start-page: 791
  year: 1992
  ident: 232_CR4
  publication-title: Eur Respir J
  doi: 10.1183/09031936.93.05070791
  contributor:
    fullname: U. Costabel
– volume: 25
  start-page: 388
  year: 2002
  ident: 232_CR10
  publication-title: Am J Clin Oncol
  doi: 10.1097/00000421-200208000-00014
  contributor:
    fullname: F. Gagnadoux
– volume: 25
  start-page: 1539
  year: 2007
  ident: 232_CR27
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.09.6305
  contributor:
    fullname: B.J. Giantonio
– volume: 9
  start-page: 177
  year: 2010
  ident: 232_CR22
  publication-title: Clin Colorectal Cancer
  doi: 10.3816/CCC.2010.n.024
  contributor:
    fullname: M.H. Fekrazad
– volume: 20
  start-page: 1
  issue: 4Suppl3
  year: 1993
  ident: 232_CR28
  publication-title: Semin Oncol
  contributor:
    fullname: E.K. Rowinsky
– volume: 102
  start-page: 273
  year: 2008
  ident: 232_CR17
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2007.09.001
  contributor:
    fullname: B.E. Wilcox
– volume: 14
  start-page: 213
  year: 2007
  ident: 232_CR6
  publication-title: Curr Med Chem
  doi: 10.2174/092986707779313345
  contributor:
    fullname: V.L. Kinnula
– volume: 132
  start-page: 1997
  year: 2007
  ident: 232_CR16
  publication-title: Chest
  doi: 10.1378/chest.07-0536
  contributor:
    fullname: M. Garrido
– volume: 18
  start-page: 243
  year: 2001
  ident: 232_CR9
  publication-title: Eur Respir J
  doi: 10.1183/09031936.01.18010243
  contributor:
    fullname: R. Trisolini
– volume: 357
  start-page: 2040
  year: 2007
  ident: 232_CR26
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa071834
  contributor:
    fullname: D.J. Jonker
– volume: 11
  start-page: 332
  year: 2009
  ident: 232_CR20
  publication-title: Clin Transl Oncol
  doi: 10.1007/s12094-009-0364-4
  contributor:
    fullname: C. Pena Alvarez
– volume: 145
  start-page: 54
  year: 2008
  ident: 232_CR25
  publication-title: Int Arch Allergy Immuno
  doi: 10.1159/000107467
  contributor:
    fullname: M. Pagani
– volume: 350
  start-page: 2343
  year: 2004
  ident: 232_CR1
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa032709
  contributor:
    fullname: T. André
SSID ssj0057501
Score 1.9026939
Snippet A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen.On the 12th cycle,we observed erythema and...
A 79-year-old man was diagnosed as stage IV colon cancer and treated with a modified FOLFOX6 (mFOLFOX6) regimen. On the 12th cycle, we observed erythema and...
SourceID pubmedcentral
crossref
pubmed
springer
chongqing
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 232
SubjectTerms Case Report
Medicine
Medicine & Public Health
免疫球蛋白E
嗜酸性粒细胞
奥沙利铂
治疗方案
甲基强的松龙
肺损伤
诱导
过敏性反应
Title Oxaliplatin-Induced Lung Injury with Allergic Reaction
URI http://lib.cqvip.com/qk/85190X/201103/40050252.html
https://link.springer.com/article/10.1007/s11670-011-0232-y
https://www.ncbi.nlm.nih.gov/pubmed/23467619
https://pubmed.ncbi.nlm.nih.gov/PMC3587561
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwED7RLrAgEK8UqDIwgdwmcZ5jVVq14ikeElvkODYU0VBoK9F_z13SBBWJBWXIYEuxvth3n-277wBOuKMVV47HZGhp5mrBWRQqznSqI48nrkgU5Q4P7oPrp_C8RzI5XpkLkwfty2TUyt7GrWz0ksdWTsayXcaJtW-vutxDlu3b7RrUkBuWW_TC_CL9yGse07k1I-WR8iozz5ezfaqzQqeCyCTYgqSAOZoKn4R21tHeZM8f6DFWfFTlmH4HTf66Oc0dUn8LNpdM0uwUI96GNZXtgH_zhcR6QgFuGaOyHFKl5iUuaHOYvSJ8Jp27mh3K_0OTZ96pIq9hFx77vYfugC1LIzCJ_GbGIhHJAJmXlNpy7YSq8iWh5hZ5d2QsPE3sMCWdHtcRuGETOnJ1FDj45hxJjsf3oJ69Z-oATKEiO1GedgJLuLjZEEjJNNIGkVoSH8uARgVMPCkkMGKXdGMczzHgtESqavsRQia0Y0Q7JrTjhQH7BYRV1xJ8A4IVcKsOJH692oJzIhfBXs4BA87K3xAvV9_07xE0_v2dQ9goTpMpuuwI6rPPuTqG2jSdN5GIDy-a-ST8BuPk3D0
link.rule.ids 230,315,729,782,786,887,27934,27935,53802,53804
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT4NAEJ5oPdSLj_jCJwdPmm2BhQJHo23a2FajNfFGlmXXRxSrton9985AwbSJl4YDh90EmGFnvp2d-QbglDtaceV4TAaWZq4WnIWB4kwnOvR47IpYUe1w-97vPwZXTaLJ8YpamCxpX8YvtfTtvZa-PGe5lcN3WS_yxOq3vUvuIcpu2PVlWMH1ajnFJj03wAhAsq7HFLlmxD1SHGZmFXN2gzqtUFwQsQSbEBkwR2PRIKqdKlqc9OkTfcaMlypd03za5NzZaeaSWusLfswGrE0xqHmRD2_Ckkq3oHHzg5B8SKlxKaOGHlIlZhdNgdlJX1HwJkVszQuqHERjad6pvCJiGx5azcFlm02bKjCJyGjEQhFKHzGblNpy7Zj6-cWB5hbhAsQ6PIntICGGH9cRuNUTOnR16Dt45xzhkcd3oJJ-pGoPTKFCO1aednxLuLhNEQjmNAIOkVgSL8uA_VKg0TAnz4hcYpxxPMeAs0LC5dgfhTJpKUItRaSlaGLAbi76cmqhNAP8GaWUE4g2e3YEFZDRZ08FbsB5ob5oum6__3-D_YWfcwLV9qDXjbqd_vUBrOYxacpRO4TK6GusjmD5OxkfZ7_wL21l8NE
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDLZ4SMCFh3h1vHrgBAprmz6PE2wCMQbiIXGr0jSBISiDbRL799jtWrRJXEA99JBIbe3G_uLYnwEOuaMVV47HZGhp5mrBWRQqznSqI48nrkgU1Q6f3wWdx_CsSTQ5VauvPGlfJt2T7PXtJOs-57mVvTdZL_PE6jdXp9xDlO3b9V6q67Mwj2vWcsuNemGEEYTknY8pes2If6Q80Myr5myfuq1QbBDxBBsRITBHg-ET3c4iWp3s6QP9xoSnqtzTdOrk1Plp7pZaK__4oFVYHmNRs1FMWYMZla2Df_2F0LxHKXIZo8YeUqVmG02CeZG9oAJMityaDaogRKNp3qqiMmIDHlrN-9NzNm6uwCQipAGLRCQDxG5Sasu1E-rrl4SaW4QPEPPwNLHDlJh-XEfglk_oyNVR4OCdc4RJHt-Euew9U9tgChXZifK0E1jCxe2KQFCnEXiI1JJ4WQbUKqHGvYJEI3aJecbxHAOOSilXYz9UyqSpGDUVk6bikQFbhfirqaXiDAgmFFNNIPrsyRFUQk6jPRa6AcelCuPx-u3__ga1Pz_nABZuzlpx-6JzuQNLRWiaUtV2YW7wOVR7MNtPh_v5X_wNNnbzUQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oxaliplatin-induced+lung+injury+with+allergic+reaction&rft.jtitle=Chinese+journal+of+cancer+research&rft.au=Homma%2C+Tetsuya&rft.au=Kurokawa%2C+Masatsugu&rft.au=Yamamoto%2C+Yoshitaka&rft.au=Matsukura%2C+Satoshi&rft.date=2011-09-01&rft.pub=Chinese+Anti-Cancer+Association&rft.issn=1000-9604&rft.eissn=1993-0631&rft.volume=23&rft.issue=3&rft_id=info:doi/10.1007%2Fs11670-011-0232-y&rft.externalDocID=10_1007_s11670_011_0232_y
thumbnail_s http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85190X%2F85190X.jpg